FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892138825> ?p ?o ?g. }

• W2892138825 endingPage "1851" @default.
• W2892138825 startingPage "1831" @default.
• W2892138825 abstract "Despite advances in insulin therapies, patients with type 1 diabetes (T1DM) have a shorter life span due to hyperglycaemia-induced vascular disease and hypoglycaemic complications secondary to insulin therapy. Restricting therapy for T1DM to insulin replacement is perhaps an over-simplistic approach, and we focus in this work on reviewing the role of adjuvant therapy in this population. Current data suggest that adding metformin to insulin therapy in T1DM temporarily lowers HbA1c and reduces weight and insulin requirements, but this treatment fails to show a longer-term glycaemic benefit. Agents in the sodium glucose co-transporter-2 inhibitor (SGLT-2) class demonstrate the greatest promise in correcting hyperglycaemia, but there are safety concerns in relation to the risk of diabetic ketoacidosis. Glucagon-like peptide-1 agonists (GLP-1) show a modest effect on glycaemia, if any, but significantly reduce weight, which may make them suitable for use in overweight T1DM patients. Treatment with pramlintide is not widely available worldwide, although there is evidence to indicate that this agent reduces both HbA1c and weight in T1DM. A criticism of adjuvant studies is the heavy reliance on HbA1c as the primary endpoint while generally ignoring other glycaemic parameters. Moreover, vascular risk markers and measures of insulin resistance—important considerations in individuals with a longer T1DM duration—are yet to be fully investigated following adjuvant therapies. Finally, studies to date have made the assumption that T1DM patients are a homogeneous group of individuals who respond similarly to adjuvant therapies, which is unlikely to be the case. Future longer-term adjuvant studies investigating different glycaemic parameters, surrogate vascular markers and harder clinical outcomes will refine our understanding of the roles of such therapies in various subgroups of T1DM patients." @default.
• W2892138825 created "2018-09-27" @default.
• W2892138825 creator A5016545097 @default.
• W2892138825 creator A5035588730 @default.
• W2892138825 creator A5086223086 @default.
• W2892138825 creator A5089408098 @default.
• W2892138825 date "2018-09-12" @default.
• W2892138825 modified "2023-10-09" @default.
• W2892138825 title "Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?" @default.
• W2892138825 cites W140545298 @default.
• W2892138825 cites W1415500254 @default.
• W2892138825 cites W1604596593 @default.
• W2892138825 cites W1752045965 @default.
• W2892138825 cites W1806569300 @default.
• W2892138825 cites W1946307024 @default.
• W2892138825 cites W1975628529 @default.
• W2892138825 cites W1982803765 @default.
• W2892138825 cites W1987036018 @default.
• W2892138825 cites W2000106622 @default.
• W2892138825 cites W2016337445 @default.
• W2892138825 cites W2028720966 @default.
• W2892138825 cites W2032167210 @default.
• W2892138825 cites W2036162803 @default.
• W2892138825 cites W2040132182 @default.
• W2892138825 cites W2054705005 @default.
• W2892138825 cites W2060328826 @default.
• W2892138825 cites W2065786925 @default.
• W2892138825 cites W2069269493 @default.
• W2892138825 cites W2074517754 @default.
• W2892138825 cites W2075714988 @default.
• W2892138825 cites W2078386940 @default.
• W2892138825 cites W2091217304 @default.
• W2892138825 cites W2099670937 @default.
• W2892138825 cites W2111155556 @default.
• W2892138825 cites W2113425498 @default.
• W2892138825 cites W2119405541 @default.
• W2892138825 cites W2124022323 @default.
• W2892138825 cites W2126969411 @default.
• W2892138825 cites W2127679612 @default.
• W2892138825 cites W2139075957 @default.
• W2892138825 cites W2141428319 @default.
• W2892138825 cites W2146264128 @default.
• W2892138825 cites W2147602249 @default.
• W2892138825 cites W2152918233 @default.
• W2892138825 cites W2163890335 @default.
• W2892138825 cites W2170069518 @default.
• W2892138825 cites W2175219657 @default.
• W2892138825 cites W2185178624 @default.
• W2892138825 cites W2235343273 @default.
• W2892138825 cites W2291407037 @default.
• W2892138825 cites W2346591553 @default.
• W2892138825 cites W2480705961 @default.
• W2892138825 cites W2494601841 @default.
• W2892138825 cites W2500198996 @default.
• W2892138825 cites W2514658869 @default.
• W2892138825 cites W2517901119 @default.
• W2892138825 cites W2549197160 @default.
• W2892138825 cites W2593661359 @default.
• W2892138825 cites W2600960936 @default.
• W2892138825 cites W2603687561 @default.
• W2892138825 cites W2620916492 @default.
• W2892138825 cites W2624031057 @default.
• W2892138825 cites W2626839453 @default.
• W2892138825 cites W2738470483 @default.
• W2892138825 cites W2754413603 @default.
• W2892138825 cites W2754426117 @default.
• W2892138825 cites W2755899227 @default.
• W2892138825 cites W2756104796 @default.
• W2892138825 cites W2782858113 @default.
• W2892138825 cites W2793249329 @default.
• W2892138825 cites W2793504146 @default.
• W2892138825 cites W2793706442 @default.
• W2892138825 cites W2884284595 @default.
• W2892138825 cites W2971215853 @default.
• W2892138825 doi "https://doi.org/10.1007/s13300-018-0496-z" @default.
• W2892138825 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6167310" @default.
• W2892138825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30209797" @default.
• W2892138825 hasPublicationYear "2018" @default.
• W2892138825 type Work @default.
• W2892138825 sameAs 2892138825 @default.
• W2892138825 citedByCount "19" @default.
• W2892138825 countsByYear W28921388252016 @default.
• W2892138825 countsByYear W28921388252018 @default.
• W2892138825 countsByYear W28921388252019 @default.
• W2892138825 countsByYear W28921388252020 @default.
• W2892138825 countsByYear W28921388252021 @default.
• W2892138825 countsByYear W28921388252022 @default.
• W2892138825 countsByYear W28921388252023 @default.
• W2892138825 crossrefType "journal-article" @default.
• W2892138825 hasAuthorship W2892138825A5016545097 @default.
• W2892138825 hasAuthorship W2892138825A5035588730 @default.
• W2892138825 hasAuthorship W2892138825A5086223086 @default.
• W2892138825 hasAuthorship W2892138825A5089408098 @default.
• W2892138825 hasBestOaLocation W28921388251 @default.
• W2892138825 hasConcept C121608353 @default.
• W2892138825 hasConcept C126322002 @default.
• W2892138825 hasConcept C134018914 @default.
• W2892138825 hasConcept C177713679 @default.

• next